PoliticalRepoPoliticalRepo

United Kingdom · Question · Written question

UIN 803

Mast Cell Activation Syndrome: Health Services

Original

answeredUnited Kingdom· UK Parliament· EN

Introduced

13 May 2026

Last action

30 June 2026 · Answer

Status

Answered

Sponsors

Subjects

Discovery layer

Source updated

30 June 2026

Summary

To ask the Secretary of State for Health and Social Care, what guidance is provided to NHS Trusts on the diagnosis and management of Mast Cell Activation Syndrome in the absence of traditional allergy markers.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 13 May 2026

    Written question

    To ask the Secretary of State for Health and Social Care, what guidance is provided to NHS Trusts on the diagnosis and management of Mast Cell Activation Syndrome in the absence of traditional allergy markers.

    Source: Commons

  2. 30 June 2026

    Answer

    There is currently no National Institute for Health and Care Excellence (NICE) clinical guideline specifically covering the diagnosis and management of mast cell activation syndrome (MCAS). In the absence of condition‑specific national guidance, clinician...

    Source: Written answer

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.